[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
December 2015

Moving Toward Economically Sustainable Value-Based Cancer Care in the Academic Setting

Author Affiliations
  • 1Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, California
  • 2RAND Project Air Force, Santa Monica, California
  • 3City of Hope National Medical Center, Duarte, California

Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA Oncol. 2015;1(9):1221-1222. doi:10.1001/jamaoncol.2015.3449

The National Cancer Institute estimates that expenditures related to cancer care are likely to rise to $158 billion by 2020.1 Passage of the Affordable Care Act (ACA) has provoked a reorganization of the health care system and a drive to reduce costs. A number of organizations have proposed value frameworks and novel payment models. These include proposals from the American Society of Clinical Oncology2 and the Brookings Institute/MITRE Technical Expert Panel for Oncology.3 While the immediate focus is on cost reduction,2 the long-term goal is to incentivize a transition from transaction-based payment to a system that rewards value delivery.4